AAPL294.30-2.71 (-0.91%) ▼|ABBV234.76+4.75 (+2.07%) ▲|ABT90.53+2.70 (+3.07%) ▲|ACN127.01+2.18 (+1.75%) ▲|ADBE197.43+2.53 (+1.30%) ▲|AMAT585.88-54.30 (-8.48%) ▼|AMD519.85-31.78 (-5.76%) ▼|AMGN347.01+2.29 (+0.66%) ▲|AMT179.38+2.95 (+1.67%) ▲|AMZN234.11+1.32 (+0.57%) ▲|AVGO380.15-11.98 (-3.06%) ▼|AXP337.78-0.29 (-0.09%) ▼|BA216.71-4.12 (-1.87%) ▼|BAC57.91+0.54 (+0.94%) ▲|BKNG168.94+1.17 (+0.70%) ▲|BLK1,015.33-36.41 (-3.46%) ▼|BMY55.53+0.83 (+1.52%) ▲|BNY147.29+0.85 (+0.58%) ▲|BRK-B492.81+4.12 (+0.84%) ▲|C144.97-0.70 (-0.48%) ▼|CAT984.24-38.04 (-3.72%) ▼|CL91.43+2.76 (+3.11%) ▲|CMCSA22.80+0.48 (+2.15%) ▲|COF197.81-2.89 (-1.44%) ▼|COP109.97+0.27 (+0.25%) ▲|COST957.68+6.33 (+0.67%) ▲|CRM153.42+3.30 (+2.20%) ▲|CSCO121.15-0.38 (-0.31%) ▼|CVS101.57+0.27 (+0.27%) ▲|CVX175.98+0.92 (+0.53%) ▲|DE591.94-6.65 (-1.11%) ▼|DHR178.97+0.78 (+0.44%) ▲|DIS103.53+1.08 (+1.05%) ▲|DUK125.05+1.53 (+1.24%) ▲|EMR143.14-7.07 (-4.71%) ▼|FDX317.24-11.54 (-3.51%) ▼|GD350.34+6.98 (+2.03%) ▲|GE356.47+1.35 (+0.38%) ▲|GEV1,034.98-92.61 (-8.21%) ▼|GILD125.05+0.18 (+0.14%) ▲|GM78.95-1.48 (-1.84%) ▼|GOOG346.08-2.70 (-0.77%) ▼|GOOGL346.13-3.43 (-0.98%) ▼|GS1,094.44-11.93 (-1.08%) ▼|HD324.45-2.17 (-0.66%) ▼|HON222.37-5.74 (-2.52%) ▼|IBM264.94+12.72 (+5.04%) ▲|INTC132.28-8.66 (-6.14%) ▼|INTU258.05+0.28 (+0.11%) ▲|ISRG403.18+0.23 (+0.06%) ▲|JNJ239.08+7.79 (+3.37%) ▲|JPM334.14+2.66 (+0.80%) ▲|KO80.31+0.78 (+0.98%) ▲|LIN512.26-4.45 (-0.86%) ▼|LLY1,107.08+5.00 (+0.45%) ▲|LMT503.67+10.07 (+2.04%) ▲|LOW213.54-0.86 (-0.40%) ▼|LRCX371.33-38.21 (-9.33%) ▼|MA488.07+3.98 (+0.82%) ▲|MCD271.66+1.56 (+0.58%) ▲|MDLZ61.06+1.55 (+2.60%) ▲|MDT80.63+1.36 (+1.72%) ▲|META562.20-1.65 (-0.29%) ▼|MMM161.84-1.38 (-0.85%) ▼|MO71.61+2.10 (+3.02%) ▲|MRK119.60+4.12 (+3.57%) ▲|MS226.03-1.06 (-0.47%) ▼|MSFT373.94+6.60 (+1.80%) ▲|MU1,051.77-159.61 (-13.18%) ▼|NEE86.43+0.35 (+0.41%) ▲|NFLX72.82-0.06 (-0.08%) ▼|NKE42.38-0.81 (-1.88%) ▼|NOW95.94+2.93 (+3.15%) ▲|NVDA200.04-8.61 (-4.13%) ▼|ORCL165.16-9.91 (-5.66%) ▼|PEP142.05+1.34 (+0.95%) ▲|PFE24.72-0.36 (-1.44%) ▼|PG150.86+3.18 (+2.15%) ▲|PLTR116.70-2.80 (-2.34%) ▼|PM178.69+5.52 (+3.19%) ▲|QCOM204.13-17.77 (-8.01%) ▼|RTX186.39+4.56 (+2.51%) ▲|SBUX101.05+0.90 (+0.90%) ▲|SCHW93.17+1.14 (+1.24%) ▲|SO94.93+1.50 (+1.61%) ▲|SPG216.74+2.17 (+1.01%) ▲|T22.81+0.71 (+3.21%) ▲|TMO469.35+5.34 (+1.15%) ▲|TMUS184.57+4.51 (+2.50%) ▲|TSLA381.61-23.44 (-5.79%) ▼|TXN304.36-27.92 (-8.40%) ▼|UBER69.67-1.76 (-2.46%) ▼|UNH409.25+2.57 (+0.63%) ▲|UNP258.61-1.30 (-0.50%) ▼|UPS105.83-1.41 (-1.31%) ▼|USB60.05+1.37 (+2.33%) ▲|V328.48+1.88 (+0.58%) ▲|VZ46.73+1.37 (+3.02%) ▲|WFC84.13+0.29 (+0.35%) ▲|WMT119.42+2.24 (+1.91%) ▲|XOM139.73+1.26 (+0.91%) ▲|AAPL294.30-2.71 (-0.91%) ▼|ABBV234.76+4.75 (+2.07%) ▲|ABT90.53+2.70 (+3.07%) ▲|ACN127.01+2.18 (+1.75%) ▲|ADBE197.43+2.53 (+1.30%) ▲|AMAT585.88-54.30 (-8.48%) ▼|AMD519.85-31.78 (-5.76%) ▼|AMGN347.01+2.29 (+0.66%) ▲|AMT179.38+2.95 (+1.67%) ▲|AMZN234.11+1.32 (+0.57%) ▲|AVGO380.15-11.98 (-3.06%) ▼|AXP337.78-0.29 (-0.09%) ▼|BA216.71-4.12 (-1.87%) ▼|BAC57.91+0.54 (+0.94%) ▲|BKNG168.94+1.17 (+0.70%) ▲|BLK1,015.33-36.41 (-3.46%) ▼|BMY55.53+0.83 (+1.52%) ▲|BNY147.29+0.85 (+0.58%) ▲|BRK-B492.81+4.12 (+0.84%) ▲|C144.97-0.70 (-0.48%) ▼|CAT984.24-38.04 (-3.72%) ▼|CL91.43+2.76 (+3.11%) ▲|CMCSA22.80+0.48 (+2.15%) ▲|COF197.81-2.89 (-1.44%) ▼|COP109.97+0.27 (+0.25%) ▲|COST957.68+6.33 (+0.67%) ▲|CRM153.42+3.30 (+2.20%) ▲|CSCO121.15-0.38 (-0.31%) ▼|CVS101.57+0.27 (+0.27%) ▲|CVX175.98+0.92 (+0.53%) ▲|DE591.94-6.65 (-1.11%) ▼|DHR178.97+0.78 (+0.44%) ▲|DIS103.53+1.08 (+1.05%) ▲|DUK125.05+1.53 (+1.24%) ▲|EMR143.14-7.07 (-4.71%) ▼|FDX317.24-11.54 (-3.51%) ▼|GD350.34+6.98 (+2.03%) ▲|GE356.47+1.35 (+0.38%) ▲|GEV1,034.98-92.61 (-8.21%) ▼|GILD125.05+0.18 (+0.14%) ▲|GM78.95-1.48 (-1.84%) ▼|GOOG346.08-2.70 (-0.77%) ▼|GOOGL346.13-3.43 (-0.98%) ▼|GS1,094.44-11.93 (-1.08%) ▼|HD324.45-2.17 (-0.66%) ▼|HON222.37-5.74 (-2.52%) ▼|IBM264.94+12.72 (+5.04%) ▲|INTC132.28-8.66 (-6.14%) ▼|INTU258.05+0.28 (+0.11%) ▲|ISRG403.18+0.23 (+0.06%) ▲|JNJ239.08+7.79 (+3.37%) ▲|JPM334.14+2.66 (+0.80%) ▲|KO80.31+0.78 (+0.98%) ▲|LIN512.26-4.45 (-0.86%) ▼|LLY1,107.08+5.00 (+0.45%) ▲|LMT503.67+10.07 (+2.04%) ▲|LOW213.54-0.86 (-0.40%) ▼|LRCX371.33-38.21 (-9.33%) ▼|MA488.07+3.98 (+0.82%) ▲|MCD271.66+1.56 (+0.58%) ▲|MDLZ61.06+1.55 (+2.60%) ▲|MDT80.63+1.36 (+1.72%) ▲|META562.20-1.65 (-0.29%) ▼|MMM161.84-1.38 (-0.85%) ▼|MO71.61+2.10 (+3.02%) ▲|MRK119.60+4.12 (+3.57%) ▲|MS226.03-1.06 (-0.47%) ▼|MSFT373.94+6.60 (+1.80%) ▲|MU1,051.77-159.61 (-13.18%) ▼|NEE86.43+0.35 (+0.41%) ▲|NFLX72.82-0.06 (-0.08%) ▼|NKE42.38-0.81 (-1.88%) ▼|NOW95.94+2.93 (+3.15%) ▲|NVDA200.04-8.61 (-4.13%) ▼|ORCL165.16-9.91 (-5.66%) ▼|PEP142.05+1.34 (+0.95%) ▲|PFE24.72-0.36 (-1.44%) ▼|PG150.86+3.18 (+2.15%) ▲|PLTR116.70-2.80 (-2.34%) ▼|PM178.69+5.52 (+3.19%) ▲|QCOM204.13-17.77 (-8.01%) ▼|RTX186.39+4.56 (+2.51%) ▲|SBUX101.05+0.90 (+0.90%) ▲|SCHW93.17+1.14 (+1.24%) ▲|SO94.93+1.50 (+1.61%) ▲|SPG216.74+2.17 (+1.01%) ▲|T22.81+0.71 (+3.21%) ▲|TMO469.35+5.34 (+1.15%) ▲|TMUS184.57+4.51 (+2.50%) ▲|TSLA381.61-23.44 (-5.79%) ▼|TXN304.36-27.92 (-8.40%) ▼|UBER69.67-1.76 (-2.46%) ▼|UNH409.25+2.57 (+0.63%) ▲|UNP258.61-1.30 (-0.50%) ▼|UPS105.83-1.41 (-1.31%) ▼|USB60.05+1.37 (+2.33%) ▲|V328.48+1.88 (+0.58%) ▲|VZ46.73+1.37 (+3.02%) ▲|WFC84.13+0.29 (+0.35%) ▲|WMT119.42+2.24 (+1.91%) ▲|XOM139.73+1.26 (+0.91%) ▲|

18.9 C

New York

Wednesday, June 24, 2026

Commvault Signs Multi-Year Strategic Partnership with Microsoft

Biodance, the No. 1 Hydrogel Mask Brand on Amazon, Brings Viral Skincare Favorites to Amazon Prime Day

The Results Are In: IXL Helps Prevent Summer Learning Loss

Tag: protein

Jack Link’s Marks 40th Anniversary with “Christmas for Carnivores” Promotion to Celebrate National Jerky Day, June 12

The company is celebrating 40 years of protein snacking with a special 50% discount on a gift box of Jack Link's beef jerky, only...

Sionna Therapeutics Announces Presentation of Preclinical Data that Demonstrate Proprietary Dual Combination Therapies Enable Full CFTR Correction in CFHBE Model

Data featured in oral presentation and poster session at 48^th European Cystic Fibrosis Conference

Sobi and Apellis: Aspaveli®/Empaveli® Demonstrates Sustained One-Year Efficacy in Phase 3 Study for Rare Kidney Diseases

STOCKHOLM, June 6, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) and Apellis Pharmaceuticals, Inc. today presented new data from the open-label period of the Phase...

Apellis and Sobi Announce EMPAVELI® (pegcetacoplan) Showed Sustained Efficacy at One Year in Phase 3 Study for C3G and Primary IC-MPGN

WALTHAM, Mass. and STOCKHOLM, June 06, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Sobi^® (STO:SOBI) today presented new data from the open-label period of the Phase 3 VALIANT study, investigating EMPAVELI^® (pegcetacoplan) for C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN). The data were presented as part of a late-breaking session at the European Renal Association (ERA) Congress.

Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer

– This submission is supported by the pivotal Phase 3 VERITAC-2 clinical trial, results of which were recently presented at the 2025 American Society for Clinical Oncology Annual Meeting and published in The New England Journal of Medicine –

Meala Partners with dsm-firmenich to Commercialize Texturizing Protein for Meat Alternatives

PB Pea protein, a high-performance texturizer is ready for market release in Europe, bringing cleaner labels and better nutritional value to meat alternatives HAIFA, Israel,...

Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calcification at ERA 2025

Potent, selective ABCC6-targeting positive functional modulator (PFM) improved multiple markers of renal function in animal models of chronic kidney disease (CKD)

GenEditBio Announces First Patient Dosed in Investigator-Initiated Trial of GEB‑101, World’s First In Vivo CRISPR-Cas Ribonucleoprotein-Based Genome Editing Investigational Therapy for TGFBI Corneal Dystrophy

HONG KONG, BEIJING and BOSTON, June 6, 2025 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology start-up company focusing on genome editing therapeutic solutions...

NEFECON®: New Results at ERA 2025 Demonstrate Treatment Benefit of the ‘Treat Early’ Strategy

Two new studies on NEFECON® demonstrate its treatment benefit in the "Treat Early" strategy for IgA nephropathy (IgAN), providing robust support for the new disease...

Coffee Island debuts in Delhi with its first ever 24/7 café in GK II

The new café is strategically located to position the brand at the heart of Delhi's high-street coffee culture NEW DELHI, June 6, 2025 /PRNewswire/ --...

HTL Biotechnology inaugurates a new production line dedicated to sterile hyaluronic acid

JAVENÉ, France, June 6, 2025 /PRNewswire/ -- On the occasion of National Bioproduction and Biomedicines Day (JNBB), which enjoys the high patronage of the President...

Friedreich’s Ataxia Market Poised for Rapid Expansion During the Forecast Period (2025-2034) as Drug Pipeline Gains Momentum | DelveInsight

The dynamics of the Friedreich's ataxia market are anticipated to change as companies across the globe are thoroughly working toward the development of new...

Maple Leaf Foods Releases 2024 Integrated Report Highlighting Sustainability and Strategic Achievements

Purpose-driven consumer packaged goods protein company continues unwavering commitment to sustainability, shared value, and strategic growth MISSISSAUGA, ON, June 5, 2025 /PRNewswire/ - (TSX: MFI)...

Superbrewed Food Announces Clinical Study of Postbiotic Cultured Protein Benefits

NEW CASTLE, Del., June 5, 2025 /PRNewswire/ -- Superbrewed Food, a trailblazer in innovative food ingredients, is proud to announce the presentation of research...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsProtein